CBD tested as shield against Chemo's nerve pain

NCT ID NCT07167446

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase trial tests whether taking CBD capsules can prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with colorectal cancer. Thirty participants will be randomly assigned to receive either CBD plus standard chemo or chemo alone. The main goal is to see if patients can stick with the CBD regimen, not yet to prove it works.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
cannabidiol (CBD) capsules
What this could lead to
If it works, this could point toward a way to prevent painful nerve damage from chemotherapy, improving quality of life for cancer patients.
What could go wrong
This is a very early, small pilot study with only 30 people. It mainly tests feasibility, not effectiveness. CBD may not prevent neuropathy, and side effects or interactions with chemo are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fox Chase Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19111, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.